Indivior Pharmaceuticals, Inc. INDV Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $251M+3,686% | $209M+2,886% | $128M+381% | $108M+209% | -$7M+79.1% | ||
| $9M-35.7% | $10M-37.5% | $13M-11.9% | $14M-3.4% | $14M-13.8% | ||
| $29M+20.8% | $26M+8.3% | $27M+16.1% | $26M+15.6% | $24M+10.3% | ||
| -$111M— | -$27M— | —— | —— | —— | ||
| $81M+153% | $66M+128% | $58M+287% | $45M+350% | $32M+300% | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| -$80M-305% | -$66M-196% | -$34M-191% | $21M+198% | $39M+184% | ||
| —— | —— | —— | —— | $148M+144% | ||
| —— | —— | —— | —— | $249M+200% | ||
| $346M+42.4% | $17M-92.9% | $250M+4,900% | $247M+3,429% | $243M+2,330% | ||
| -$6M— | -$30M— | —— | —— | —— | ||
| -$197M-259% | -$124M-4,233% | $159M+211% | $206M+185% | $124M+130% | ||
| -$192M— | -$93M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Indivior Pharmaceuticals, Inc. 's cash flow data come from?
- Every line is extracted from Indivior Pharmaceuticals, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.